首页 > 最新文献

Surgery, Gastroenterology and Oncology最新文献

英文 中文
C-KIT Negative Gastrointestinal Stromal Tumors: Challenges of Management and Prognosis C-KIT阴性胃肠道间质瘤:管理和预后的挑战
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-517
M. A. ElKordy, Fady Rashad Selim, Amani A. Abou, Eman D. ElDesouky, Foad AbdElShaheed Foad
{"title":"C-KIT Negative Gastrointestinal Stromal Tumors: Challenges of Management and Prognosis","authors":"M. A. ElKordy, Fady Rashad Selim, Amani A. Abou, Eman D. ElDesouky, Foad AbdElShaheed Foad","doi":"10.21614/sgo-517","DOIUrl":"https://doi.org/10.21614/sgo-517","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85930674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diamond Versus V-Y Advancement Flaps for Management of Anal Stenosis: Efficacy and Outcomes 钻石与V-Y推进皮瓣治疗肛门狭窄:疗效和结果
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-382
A. Darwish, Kareem A. Kame, Moheb S. Eskandaros
{"title":"Diamond Versus V-Y Advancement Flaps for Management of Anal Stenosis: Efficacy and Outcomes","authors":"A. Darwish, Kareem A. Kame, Moheb S. Eskandaros","doi":"10.21614/sgo-382","DOIUrl":"https://doi.org/10.21614/sgo-382","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85256599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative Movement of an Internal Stent Placed at the Anastomotic Site of Pancreaticojejunostomy During Pancreaticoduodenectomy 胰十二指肠切除术中胰空肠吻合术吻合口内支架的术后运动
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-431
T. Usuba, Ryusuke Ito, Masashi Tsunematsu, Ryota Iwase, Yu Kumagai, T. Iida, Masaichi Ogawa, Toru Ikegami
{"title":"Postoperative Movement of an Internal Stent Placed at the Anastomotic Site of Pancreaticojejunostomy During Pancreaticoduodenectomy","authors":"T. Usuba, Ryusuke Ito, Masashi Tsunematsu, Ryota Iwase, Yu Kumagai, T. Iida, Masaichi Ogawa, Toru Ikegami","doi":"10.21614/sgo-431","DOIUrl":"https://doi.org/10.21614/sgo-431","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85382363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Spleen Doses on the Hematological Parameters in Adjuvant Gastric Cancer Radiotherapy 脾脏剂量对胃癌辅助放疗中血液学参数的影响
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-493
G. Inan, Ipek Pinar Aral, Binnur Tuncer, Tarık Kargıoğlu, Feyza YAŞAR DAŞGIN, S. AYTAÇ ARSLAN, Y. Tezcan
Aim: This study aimed to examine whether there is a relationship between spleen radiation doses and hematological parameters in gastric cancer patients. Materials and Methods: The patients who received chemoradiotherapy for nonmetastatic locally advanced gastric cancer were analyzed retrospectively. The dose parameters evaluated were spleen V5, V10, V15, V20, V25, V30 and mean spleen dose (MSD). Blood tests were evaluated at the beginning of the treatment (basal), in the 12-14 fractions of the treatment (mid-treatment), in the first week after the end of the treatment (at the end of treatment) and 3th month control after radiotherapy. The CTCAE (Common Toxicity Criteria for Adverse Events) ver 5.0 was used. The SPSS 26 (IBM Corp, Armonk, NY) was used for statistical analysis. Results: The data of 28 patients with gastric adenocarcinoma who received curative-adjuvant radiotherapy (RT) were evaluated retrospectively. The median age of the patients was 63 years (range 33-81). The median total dose was 45 (range 41.40-55) Gy.There were not statically significant relationships between any platelet or absolute lymphocyte count (mid treatment, end of the treatment and 3. months control) and splenic does.The statically significant relationships were found between mid-treatment absolute neutrophil count and mean splenic dose (p=0.044); spleen V10 doses (p=0.030); spleen V15 doses (p=0.031); spleenV20 doses (p=0.044).There were statically significant difference between at the third months control after treatment absolute neutrophil count and mean splenic dose (p=0.037), spleen V30 (p=0.039). Conclusion: A significant relationship was found between mid treatment, at the third month control neutropenia and spleen mean splenic dose, spleen V10 doses, spleen V15 doses, spleen V20 doses in gastric cancers.
目的:探讨胃癌患者脾辐射剂量与血液学参数的关系。材料与方法:回顾性分析非转移性局部进展期胃癌放化疗患者的临床资料。评估剂量参数为脾脏V5、V10、V15、V20、V25、V30和脾脏平均剂量(MSD)。在治疗开始时(基础)、治疗12-14个阶段(治疗中期)、治疗结束后第一周(治疗结束时)和放疗后第3个月对照时进行血液检查。使用CTCAE(不良事件常见毒性标准)5.0版。使用SPSS 26 (IBM Corp ., Armonk, NY)进行统计分析。结果:对28例胃腺癌患者行治疗辅助放疗的资料进行回顾性分析。患者的中位年龄为63岁(33-81岁)。中位总剂量为45 Gy(41.4 -55)。血小板或绝对淋巴细胞计数(治疗中期、治疗结束)与3。月对照)和脾对照。治疗中期中性粒细胞绝对计数与平均脾剂量有统计学意义(p=0.044);脾V10剂量(p=0.030);脾V15剂量(p=0.031);脾v20剂量(p=0.044)。治疗后第3个月对照组中性粒细胞绝对计数与脾脏平均剂量(p=0.037)、脾脏V30 (p=0.039)比较,差异均有统计学意义。结论:治疗中期、对照组第3个月中性粒细胞减少与胃癌患者脾平均剂量、脾V10剂量、脾V15剂量、脾V20剂量有显著相关。
{"title":"The Effect of Spleen Doses on the Hematological Parameters in Adjuvant Gastric Cancer Radiotherapy","authors":"G. Inan, Ipek Pinar Aral, Binnur Tuncer, Tarık Kargıoğlu, Feyza YAŞAR DAŞGIN, S. AYTAÇ ARSLAN, Y. Tezcan","doi":"10.21614/sgo-493","DOIUrl":"https://doi.org/10.21614/sgo-493","url":null,"abstract":"Aim: This study aimed to examine whether there is a relationship between spleen radiation doses and hematological parameters in gastric cancer patients. Materials and Methods: The patients who received chemoradiotherapy for nonmetastatic locally advanced gastric cancer were analyzed retrospectively. The dose parameters evaluated were spleen V5, V10, V15, V20, V25, V30 and mean spleen dose (MSD). Blood tests were evaluated at the beginning of the treatment (basal), in the 12-14 fractions of the treatment (mid-treatment), in the first week after the end of the treatment (at the end of treatment) and 3th month control after radiotherapy. The CTCAE (Common Toxicity Criteria for Adverse Events) ver 5.0 was used. The SPSS 26 (IBM Corp, Armonk, NY) was used for statistical analysis. Results: The data of 28 patients with gastric adenocarcinoma who received curative-adjuvant radiotherapy (RT) were evaluated retrospectively. The median age of the patients was 63 years (range 33-81). The median total dose was 45 (range 41.40-55) Gy.There were not statically significant relationships between any platelet or absolute lymphocyte count (mid treatment, end of the treatment and 3. months control) and splenic does.The statically significant relationships were found between mid-treatment absolute neutrophil count and mean splenic dose (p=0.044); spleen V10 doses (p=0.030); spleen V15 doses (p=0.031); spleenV20 doses (p=0.044).There were statically significant difference between at the third months control after treatment absolute neutrophil count and mean splenic dose (p=0.037), spleen V30 (p=0.039). Conclusion: A significant relationship was found between mid treatment, at the third month control neutropenia and spleen mean splenic dose, spleen V10 doses, spleen V15 doses, spleen V20 doses in gastric cancers.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76858641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perianal Extramammary Paget's Disease: A Case Report 肛周乳腺外佩吉特病1例报告
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-426
Ana Sofia Rocha Cavadas, Patricia Cristina Fernandes, Fernanda Maria da, Joaquim Manuel Costa, Sandra Fernandes Martins
{"title":"Perianal Extramammary Paget's Disease: A Case Report","authors":"Ana Sofia Rocha Cavadas, Patricia Cristina Fernandes, Fernanda Maria da, Joaquim Manuel Costa, Sandra Fernandes Martins","doi":"10.21614/sgo-426","DOIUrl":"https://doi.org/10.21614/sgo-426","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74129585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Adherence to the Use of the World Health Organization Surgical Safety Checklist Among Medical Staff in Ain Shams University Hospital, Egypt 对埃及艾因沙姆斯大学医院医务人员遵守使用世界卫生组织手术安全清单的评估
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-404
Fahmy Kmd, Mostafa Nagy, Maged El-Setouy, Jon Mark Hirshon, M. El-Shinawi
{"title":"Assessment of Adherence to the Use of the World Health Organization Surgical Safety Checklist Among Medical Staff in Ain Shams University Hospital, Egypt","authors":"Fahmy Kmd, Mostafa Nagy, Maged El-Setouy, Jon Mark Hirshon, M. El-Shinawi","doi":"10.21614/sgo-404","DOIUrl":"https://doi.org/10.21614/sgo-404","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87564073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Mortality in Cases of Obstructed Left Colonic Carcinoma 梗阻性左结肠癌死亡的危险因素
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-463
Abdelghafar Abo Elrish, Asharf Abbas, Mokhtar Farid, M. Shetiwy, Mohamed Elsaeed Abdu Mohamed, Magdy Basheer, and Abdelrahman Albahy
{"title":"Risk Factors for Mortality in Cases of Obstructed Left Colonic Carcinoma","authors":"Abdelghafar Abo Elrish, Asharf Abbas, Mokhtar Farid, M. Shetiwy, Mohamed Elsaeed Abdu Mohamed, Magdy Basheer, and Abdelrahman Albahy","doi":"10.21614/sgo-463","DOIUrl":"https://doi.org/10.21614/sgo-463","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86455062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Gelatin-Thrombin Matrix Sealants (Floseal) for Hemostasis During Liver Resection (with video) 明胶-凝血酶基质密封剂(Floseal)用于肝切除术止血的安全性和有效性(附视频)
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-518
S. Okubo, J. Shindoh, Masaru Matsumura, M. Hashimoto
{"title":"Safety and Efficacy of Gelatin-Thrombin Matrix Sealants (Floseal) for Hemostasis During Liver Resection (with video)","authors":"S. Okubo, J. Shindoh, Masaru Matsumura, M. Hashimoto","doi":"10.21614/sgo-518","DOIUrl":"https://doi.org/10.21614/sgo-518","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"105 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75692699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transversus Abdominis Release Versus Anterior Component Separation in Ventral Abdominal Hernia - A Prospective Comparative Study 腹侧疝的腹侧释放与前组分分离-一项前瞻性比较研究
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-460
M. Goda, Hossam S Abdelrahim, Haitham M. Elmaleh, Ahmed F. Amer, Ehab Mohammed Ali
{"title":"Transversus Abdominis Release Versus Anterior Component Separation in Ventral Abdominal Hernia - A Prospective Comparative Study","authors":"M. Goda, Hossam S Abdelrahim, Haitham M. Elmaleh, Ahmed F. Amer, Ehab Mohammed Ali","doi":"10.21614/sgo-460","DOIUrl":"https://doi.org/10.21614/sgo-460","url":null,"abstract":"","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"136 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82403469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Literature Review of Oropahyngeal Cancer Patients Assessed with EORTC QLQ-30 EORTC HN-35# 用EORTC QLQ-30和EORTC HN-35#评价口咽癌患者的文献综述
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-477
A. Diaconescu, Jvalant N Parekh, Valeriu Buza
Background: Oropharyngeal cancer is the most common type of head and neck cancers, with a 5-years survival of 64.7%. In the last 40 years risk factors and etiology changed, from the incidence associated mostly with tobacco and alcohol to HPV infection in 70% of the cases. Treatments that are standard of care for OPSCC include chemotherapy, radiotherapy or combination of surgery and radiotherapy have a high chronic treatment-related toxicity and functional loss. These therapies have significant impact on the quality of life (QOL) of survivors of oropharyngeal squamous cell carcinoma (OPSCC). Objectives: The objective of this study is to review literature on 1-year evolution of quality of life of patients treated for OPSCC with standard of care. Methods: A comprehensive search of the literature of treated OPSCC patients assessed with EORTC QLQ-30 EORTC H&N-35 at pre-treatment 12-month post treatment. Results: The first study showed that standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes likely caused by radiotherapy or combination of surgery and radiotherapy. Conclusions: Standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes.
背景:口咽癌是头颈部肿瘤中最常见的类型,5年生存率为64.7%。在过去40年中,风险因素和病因发生了变化,从主要与烟草和酒精相关的发病率到70%的病例中HPV感染。OPSCC的标准治疗包括化疗、放疗或手术和放疗的联合治疗,这些治疗具有很高的慢性治疗相关毒性和功能丧失。这些疗法对口咽鳞状细胞癌(OPSCC)幸存者的生活质量(QOL)有显著影响。目的:本研究的目的是回顾有关标准护理治疗OPSCC患者1年生活质量演变的文献。方法:综合检索经治疗的OPSCC患者在治疗前12个月用EORTC QLQ-30 EORTC H&N-35进行评估的文献。结果:第一项研究表明,标准护理治疗会产生慢性副作用,如口干、口腔和牙齿健康状况不佳、吞咽困难、喂食管依赖,以及其他可能由放疗或手术与放疗联合引起的纤维化改变。结论:标准护理治疗会产生慢性副作用,如口干、口腔和牙齿健康状况差、吞咽困难、饲管依赖等纤维化改变。
{"title":"Literature Review of Oropahyngeal Cancer Patients Assessed with EORTC QLQ-30 EORTC HN-35#","authors":"A. Diaconescu, Jvalant N Parekh, Valeriu Buza","doi":"10.21614/sgo-477","DOIUrl":"https://doi.org/10.21614/sgo-477","url":null,"abstract":"Background: Oropharyngeal cancer is the most common type of head and neck cancers, with a 5-years survival of 64.7%. In the last 40 years risk factors and etiology changed, from the incidence associated mostly with tobacco and alcohol to HPV infection in 70% of the cases. Treatments that are standard of care for OPSCC include chemotherapy, radiotherapy or combination of surgery and radiotherapy have a high chronic treatment-related toxicity and functional loss. These therapies have significant impact on the quality of life (QOL) of survivors of oropharyngeal squamous cell carcinoma (OPSCC). Objectives: The objective of this study is to review literature on 1-year evolution of quality of life of patients treated for OPSCC with standard of care. Methods: A comprehensive search of the literature of treated OPSCC patients assessed with EORTC QLQ-30 EORTC H&N-35 at pre-treatment 12-month post treatment. Results: The first study showed that standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes likely caused by radiotherapy or combination of surgery and radiotherapy. Conclusions: Standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89439385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery, Gastroenterology and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1